Factors to consider when assessing the IDOCS study.
| Autor: | Vinke JSJ; Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, 9700 RB, Groningen, Netherlands., Eisenga MF; Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, 9700 RB, Groningen, Netherlands. Electronic address: m.f.eisenga@umcg.nl. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Lancet. Haematology [Lancet Haematol] 2022 Sep; Vol. 9 (9), pp. e638-e639. |
| DOI: | 10.1016/S2352-3026(22)00257-5 |
| Abstrakt: | Competing Interests: JSJV reports speakers bureaus from Vifor Pharma. MFE reports consultant fees from Vifor Pharma; served on the Advisory Board for Cablon Medical; and speakers bureaus from Vifor Pharma, Cablon Medical, and Astellas. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|